Treatment of pulmonary disorders with aerosolized medicaments such as vancomycin

Details for Australian Patent Application No. 2008305591 (hide)

Owner Novartis AG

Inventors Kadrichu, Nani P.; Fink, James B.

Agent Davies Collison Cave

Pub. Number AU-A-2008305591

PCT Pub. Number WO2009/042187

Priority 60/975,094 25.09.07 US

Filing date 24 September 2008

Wipo publication date 2 April 2009

International Classifications

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 38/14 (2006.01) Medicinal preparations containing peptides - Peptides containing saccharide radicals

A61M 15/00 (2006.01) Inhaling devices

Event Publications

15 April 2010 PCT application entered the National Phase

  PCT publication WO2009/042187 Priority application(s): WO2009/042187

16 December 2010 Assignment before Grant

  Novartis AG The application has been assigned to Nektar Therapeutics

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008305596-Persitaltic pump assembly

2008305590-Genomic editing in zebrafish using zinc finger nucleases